<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 48-year-old man was referred to our hospital with the diagnosis of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> with multiple <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>After right hemicolectomy, the <z:hpo ids='HP_0003678'>rapid progression</z:hpo> of <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disease</z:e> was treated with metronomic <z:chebi fb="0" ids="31348">capecitabine</z:chebi> and bevacizumab according to a study protocol </plain></SENT>
<SENT sid="2" pm="."><plain>A gradual regression of metastatic lesions was observed during a 9-month treatment period </plain></SENT>
<SENT sid="3" pm="."><plain>After conversion of <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disease</z:e> to resectability, the histological examination disclosed the complete <z:mp ids='MP_0001651'>necrosis</z:mp> of <z:hpo ids='HP_0000001'>all</z:hpo> lesions, with the exception of small neoplastic foci inside a single nodule </plain></SENT>
<SENT sid="4" pm="."><plain>The comparison of this type of histological findings with the classic sclero-hyaline pathological response, as well as its importance as indicator of response to antiangiogenic treatment, is discussed </plain></SENT>
</text></document>